Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice of Distribution of Retained Earnings
CONSOLIDATED FINANCIAL STATEMENTS (IFRS)(Non-Audited)(for the year ended December 31, 2025)
Revision of the Stock Compensation System
Supplementary Materials Consolidated Financial Statements for the year ended December 31, 2025 (IFRS)
F. Hoffmann-La Roche Announces Financial Results for Fiscal 2025
[Update on Disclosed Matter] Notice Concerning Completion of Making Renalys Pharma, Inc. a Wholly-Owned Subsidiary and an Absorption-Type Merger
Corporate Governance Report
Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron
Notice of Absorption-Type Merger of a Wholly-Owned Subsidiary, Renalys Pharma, Inc.
CONSOLIDATED FINANCIAL STATEMENTS(IFRS)(Non-Audited)(for the nine months ended September 30, 2025)
Supplementary Materials Consolidated Financial Statements for the nine months ended September 30, 2025 (IFRS)
Notice Concerning Making Renalys Pharma, Inc. a Wholly-Owned Subsidiary
F. Hoffmann-La Roche Announces Third Quarter Sales 2025
Chugai and Rani Therapeutics Enter into a License Agreement for the Development and Commercialization of an Oral Formulation
Eli Lilly's Announcement Regarding Oral GLP-1 Orforglipron
Eli Lilly's Announcement Regarding Oral GLP-1 Orforglipron
Chugai to Construct a New Laboratory Building "UKX" to Strengthen Manufacturing Process Development Capabilities and Advance Environmental Initiatives
CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2025)
Supplementary Materials Consolidated Financial Statements for the six months ended June 30, 2025 (IFRS)
F. Hoffmann-La Roche Announces Half Year Results 2025